Covalon Technologies Ltd. (OTCMKTS:CVALF) Short Interest Update

Covalon Technologies Ltd. (OTCMKTS:CVALF) saw a significant drop in short interest in December. As of December 15th, there was short interest totalling 1,300 shares, a drop of 50.0% from the November 30th total of 2,600 shares. Based on an average trading volume of 29,100 shares, the short-interest ratio is currently 0.0 days.

Covalon Technologies Stock Down 3.6 %

Shares of OTCMKTS CVALF opened at $2.20 on Friday. The business has a 50 day moving average price of $2.50 and a two-hundred day moving average price of $2.14. Covalon Technologies has a fifty-two week low of $0.74 and a fifty-two week high of $3.08. The firm has a market cap of $60.21 million, a PE ratio of -73.23 and a beta of -0.31.

Covalon Technologies Company Profile

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.